MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?

Abstract

BACKGROUND:

MicroRNAs (miRNAs) are small, single-stranded RNA sequences that regulate gene expression on a post-transcriptional level. In the last few decades, various trials have investigated the diagnostic and therapeutic potential of miRNAs in several disease entities. Here, we provide a review of the available evidence on miRNAs in inflammatory heart diseases (myocarditis, endocarditis, and pericarditis) and sepsis-induced cardiac dysfunction.

METHODS:

Systematic database research using the PubMed and Medline databases was conducted between July and September 2019 using predefined search terms. The whole review was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

RESULTS:

In total, 131 studies were screened, 96 abstracts were read, and 69 studies were included in the review.

DISCUSSION:

In the future, circulating miRNAs could serve as biomarkers for diagnosis and disease monitoring in the context of inflammatory heart diseases and sepsis-induced cardiac dysfunction. Considering the promising results of different animal models, certain miRNAs could also emerge as novel therapeutic approaches in this setting.

• Authors: Moritz Mirna, Vera Paar, Richard Rezar, Albert Topf, Miriam Eber, Uta C Hoppe, Michael Lichtenauer, Christian Jung
• Journal: Cells (Cells) Vol. 8 Issue 11 (10 30 2019) ISSN: 2073-4409 [Electronic] Switzerland
• PMID: 31671621 (Publication Type: Journal Article, Review)

Chemical References

• Biomarkers
• MicroRNAs

Topics

• Animals
• Biomarkers (analysis)
• Heart Diseases (diagnosis, etiology, genetics)
• Humans
• Inflammation (complications)
• MicroRNAs (genetics)
• Sepsis (complications)